AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer
TAIPEI, April 13, 2026 /PRNewswire/ -- AnBogen Therapeutics, a clinical-stage biotechnology company…
New data reinforces Ipsens commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
14 abstracts will be presented across a range of neurological conditions including…
GLOBAL MANCOZEB SUMMIT: ADDRESSING ITS CRUCIAL ROLE IN CROP PROTECTION AHEAD OF EU COURT HEARING
LONDON, June 16, 2025 /PRNewswire/ -- UPL Corporation Ltd. (UPL Corp) - part…
Highstar Unveils Next-Gen Tabless Cell Series at The Battery Show Europe 2025
STUTTGART, Germany, June 5, 2025 /PRNewswire/ -- Highstar launched its next-generation Tabless Cell…
